China tightens oversight of contract manufacturers and traders
This article was originally published in Scrip
Executive Summary
Fearing the spread of fake and low-quality drugs, China's State Food and Drug Administration has issued a new regulation which came into immediate effect at the end of July that targets domestic contract drug manufacturers receiving orders from foreign buyers.